Despite the lack of randomized data comparing early salvage radiotherapy to adjuvant radiotherapy, observational studies suggest that early salvage radiotherapy reduces PSA recurrence, distant metastases, and prostate cancer specific death [19,20]. This evidence concerns the gene KLK3 and Familial prostate cancer.